Literature DB >> 8632644

Effect of rat mesenchymal stem cells on development of abdominal adhesions after surgery.

P A Lucas1, D J Warejcka, L M Zhang, W H Newman, H E Young.   

Abstract

One of the common and most serious side effects of abdominal surgery is the formation of adhesions within the peritoneal cavity during healing. Efforts to prevent adhesion formation have concentrated on inhibiting the inflammatory response, inhibiting the formation or encouraging the lysis of fibrin, and protection of the damaged serosal surface. We are interested in regenerating the serosal surface by providing a source of mesothelial progenitor cells. Rats were divided into groups of 10 each. Abdominal adhesions were created by removing a circle of peritoneum and suturing it back into place. Two weeks later the rats were euthanized and the adhesions scored on a scale of 0-5. A population of mesenchymal stem cells (MSCs) isolated from the skeletal muscle of neonatal rats was tested. The cells were grown in primary culture to expand the population and then trypsinized and frozen at -80 degrees C. They are then thawed and grown in secondary culture before use. The control group were injected with saline i.p. immediately after surgery. The experimental groups received (1) 1.4 X 10(6) MSCs, (2) 5 X 10(6) MSCs, (3) 7.5 X 10(6) dead MSCs, (4) 5 X 10(6) rat smooth muscle cells immediately post-op, and (5) 5 X 10(6) MSCs 4-6 hours after surgery. Only live MSCs given immediately after surgery by i.p. injection significantly decreased the adhesion scores of the rats (mean score of 3.5 vs 0.9). MSCs injected i.p. 4-6 hours after surgery actually increased the adhesion scores (3.5 vs 4.7), and rat smooth muscle cells injected i.p. immediately after surgery had no effect on adhesions. The exact mechanism of action of the MSCs is unknown at this time. However, we postulate that the MSCs have the capacity to differentiate into mesothelial cells capable of repopulating the injured mesothelium.

Entities:  

Mesh:

Year:  1996        PMID: 8632644     DOI: 10.1006/jsre.1996.0200

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

Review 1.  Current strategies and future perspectives for intraperitoneal adhesion prevention.

Authors:  Christoph Brochhausen; Volker H Schmitt; Constanze N E Planck; Taufiek K Rajab; David Hollemann; Christine Tapprich; Bernhard Krämer; Christian Wallwiener; Helmut Hierlemann; Rolf Zehbe; Heinrich Planck; C James Kirkpatrick
Journal:  J Gastrointest Surg       Date:  2012-06       Impact factor: 3.452

2.  Increasing anastomosis safety and preventing abdominal adhesion formation by the use of polypeptides in the rat.

Authors:  Bobby Tingstedt; László Nehéz; Jakob Axelsson; Björn Lindman; Roland Andersson
Journal:  Int J Colorectal Dis       Date:  2005-11-03       Impact factor: 2.571

3.  Mesothelial morphology and organisation after peritoneal treatment with solid and liquid adhesion barriers--a scanning electron microscopical study.

Authors:  Christoph Brochhausen; Volker H Schmitt; Taufiek K Rajab; Constanze N E Planck; Bernhard Krämer; Christine Tapprich; Markus Wallwiener; Helmut Hierlemann; Heinrich Planck; C James Kirkpatrick
Journal:  J Mater Sci Mater Med       Date:  2012-05-10       Impact factor: 3.896

Review 4.  Regenerative Medicine Therapies for Prevention of Abdominal Adhesions: A Scoping Review.

Authors:  Samuel P Carmichael; Jaewook Shin; John W Vaughan; Prafulla K Chandra; John B Holcomb; Anthony J Atala
Journal:  J Surg Res       Date:  2022-03-17       Impact factor: 2.417

Review 5.  Peritoneal changes due to laparoscopic surgery.

Authors:  W J A Brokelman; M Lensvelt; I H M Borel Rinkes; J H G Klinkenbijl; M M P J Reijnen
Journal:  Surg Endosc       Date:  2010-06-15       Impact factor: 4.584

6.  The effect of mesenchymal stem cell use on intra-abdominal adhesions in a rat model.

Authors:  Gökhan Karaca; Faruk Pehlivanli; Oktay Aydin; Canan Altunkaya; Hafize Uzun; Mehmet Niyaz; Hüseyin Özden; Huri Bulut
Journal:  Ann Surg Treat Res       Date:  2018-01-30       Impact factor: 1.859

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.